Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
16
NCT03500627
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 30, 2018
Completion: Jul 20, 2018
NCT04321980
A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers
Start: Mar 19, 2020
Completion: May 22, 2020